Mineralys grants new CMO inducement awards for 135,000 stock options, 102,400 RSUs

• Mineralys Therapeutics granted new Chief Medical Officer Terry Ferguson inducement equity awards dated Aug. 10, 2026.
• Package includes stock options covering 135,000 shares, vesting over four years with 25% at year one, then monthly.
• Also issued restricted stock units covering 102,400 shares, vesting over four years with 25% on each anniversary.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.